Zhejiang Jingxin Pharmaceutical Co.Ltd(002020) : the company plans to acquire 100% equity of Guangdong Shaxi Pharmaceutical Co., Ltd. held by related parties for RMB 205 million. Shaxi pharmaceutical is mainly engaged in the R & D, production and sales of Chinese patent medicine. It is one of the first batch of “Chinese time-honored” enterprises of the Ministry of commerce. The exclusive product “Shaxi herbal tea” is listed in the intangible cultural heritage list of Guangdong Province and the state. Hangzhou Huaxing Chuangye Communication Technology Co.Ltd(300025) : the 50.901 million shares held by the shareholder Shanghai fanyin (accounting for 11.88% of the total share capital of the company) were successfully auctioned. The controlling shareholder Hangzhou Zhaoxiang sold 30 million shares. Shanghai fanyin and Hangzhou Zhaoxiang were acting in concert. Hangzhou Zhaoxiang still has the voting rights of 10.901 million shares of the company whose ownership transfer has not been completed by Shanghai fanyin, This equity change will not lead to changes in the controlling shareholders and actual controllers of the company. Shanghai Nenghui Technology Co.Ltd(301046) : promote the incentive plan of 2.73 million restricted shares.
(Securities Times · e company)
